Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH
Jinrui Dong, Sivakumar Viswanathan, Eleonora Adami, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Targeting IL-6 trans-signalling: past, present and future prospects
Stefan Rose‐John, Brendan J. Jenkins, Christoph Garbers, et al.
Nature reviews. Immunology (2023) Vol. 23, Iss. 10, pp. 666-681
Open Access | Times Cited: 245
Inhaled siRNA nanoparticles targeting IL11 inhibit lung fibrosis and improve pulmonary function post-bleomycin challenge
Xin Bai, Guolin Zhao, Qijing Chen, et al.
Science Advances (2022) Vol. 8, Iss. 25
Open Access | Times Cited: 98
Inhibition of IL-11 signalling extends mammalian healthspan and lifespan
Anissa A. Widjaja, Wei‐Wen Lim, Siva Viswanathan, et al.
Nature (2024) Vol. 632, Iss. 8023, pp. 157-165
Open Access | Times Cited: 64
Hepatocytes: A key role in liver inflammation
Jin Gong, Wei Tu, Jingmei Liu, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 54
Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease
Xunzhe Yin, Xiangyu Guo, Zuojia Liu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2844-2844
Open Access | Times Cited: 47
Ferroptosis: principles and significance in health and disease
Fangquan Chen, Rui Kang, Daolin Tang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 44
Redefining IL11 as a regeneration-limiting hepatotoxin and therapeutic target in acetaminophen-induced liver injury
Anissa A. Widjaja, Jinrui Dong, Eleonora Adami, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 597
Open Access | Times Cited: 58
IL11 Stimulates IL33 Expression and Proinflammatory Fibroblast Activation across Tissues
Anissa A. Widjaja, Sonia Chothani, Sivakumar Viswanathan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8900-8900
Open Access | Times Cited: 49
Targeting endogenous kidney regeneration using anti-IL11 therapy in acute and chronic models of kidney disease
Anissa A. Widjaja, Sivakumar Viswanathan, Shamini G. Shekeran, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 40
Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future
João Paulo Margiotti dos Santos, Mariana Canevari de Maio, Monike Alves Lemes, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 498-498
Open Access | Times Cited: 38
Diabetes and cirrhosis: Current concepts on diagnosis and management
Laurent Castéra, Kenneth Cusi
Hepatology (2023) Vol. 77, Iss. 6, pp. 2128-2146
Closed Access | Times Cited: 38
Understanding interleukin 11 as a disease gene and therapeutic target
Stuart A. Cook
Biochemical Journal (2023) Vol. 480, Iss. 23, pp. 1987-2008
Open Access | Times Cited: 26
Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C
Tom Ryu, Young Woon Chang, Soung Won Jeong, et al.
Clinical and Molecular Hepatology (2025)
Open Access | Times Cited: 1
Metabolic-Dysfunction-Associated Steatotic Liver Disease: Molecular Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
Jeysson E. Mejía-Guzmán, Ramón A. Belmont-Hernández, Norberto C. Chávez‐Tapia, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2959-2959
Open Access | Times Cited: 1
Lutein attenuates angiotensin II- induced cardiac remodeling by inhibiting AP-1/IL-11 signaling
Youming Chen, Lan Wang, Shixing Huang, et al.
Redox Biology (2021) Vol. 44, pp. 102020-102020
Open Access | Times Cited: 52
Molecular Dissection of Pro-Fibrotic IL11 Signaling in Cardiac and Pulmonary Fibroblasts
Anissa A. Widjaja, Sivakumar Viswanathan, Jinrui Dong, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 41
Hepatocyte phosphatase DUSP22 mitigates NASH-HCC progression by targeting FAK
Chenxu Ge, Jun Tan, Xianling Dai, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 37
A Neutralizing IL-11 Antibody Improves Renal Function and Increases Lifespan in a Mouse Model of Alport Syndrome
Anissa A. Widjaja, Shamini G. Shekeran, Eleonora Adami, et al.
Journal of the American Society of Nephrology (2022) Vol. 33, Iss. 4, pp. 718-730
Open Access | Times Cited: 36
Tetramethylpyrazine prevents liver fibrotic injury in mice by targeting hepatocyte-derived and mitochondrial DNA-enriched extracellular vesicles
Yajing Li, Runping Liu, Mingning Ding, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 8, pp. 2026-2041
Open Access | Times Cited: 35
Inhibition of IL11 Signaling Reduces Aortic Pathology in Murine Marfan Syndrome
Wei‐Wen Lim, Jinrui Dong, Benjamin Ng, et al.
Circulation Research (2022) Vol. 130, Iss. 5, pp. 728-740
Open Access | Times Cited: 33
Interleukin-11 drives human and mouse alcohol-related liver disease
Maria Effenberger, Anissa A. Widjaja, Felix Grabherr, et al.
Gut (2022) Vol. 72, Iss. 1, pp. 168-179
Closed Access | Times Cited: 28
IL11 stimulates ERK/P90RSK to inhibit LKB1/AMPK and activate mTOR initiating a mesenchymal program in stromal, epithelial, and cancer cells
Anissa A. Widjaja, Sivakumar Viswanathan, Joyce Wei Ting Goh, et al.
iScience (2022) Vol. 25, Iss. 8, pp. 104806-104806
Open Access | Times Cited: 28
Nanoparticle-Mediated RNA Therapy Attenuates Nonalcoholic Steatohepatitis and Related Fibrosis by Targeting Activated Hepatic Stellate Cells
Chenshuang Zhang, Yilong Teng, Fengqiao Li, et al.
ACS Nano (2023) Vol. 17, Iss. 15, pp. 14852-14870
Closed Access | Times Cited: 18
Overview and prospect of NAFLD: Significant roles of nutrients and dietary patterns in its progression or prevention
Tianyu Mao, Yiwen Sun, Xinyi Xu, et al.
Hepatology Communications (2023) Vol. 7, Iss. 10
Open Access | Times Cited: 16
Roles of IL-11 in the regulation of bone metabolism
Yijing Han, Hui Gao, Xinling Gan, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top